探索乳腺癌表观遗传失调的复杂性及其对治疗干预措施的影响:一个全面的概述
Swathy Ravindran1,2, Ravindran Vini3, Arumugam Rajavelu4
1Cancer Research Program, Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), Thycaud PO, Thiruvananthapuram, Kerala, 695014, India.
Molecular and cellular biochemistry
|October 23, 2025
概括
表观遗传变化驱动乳腺癌的进展和治疗耐药性. 了解这些机制,包括27-胆固醇的作用,为改善患者的治疗结果提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 乳腺癌是一种复杂的疾病,由遗传和表观遗传改变驱动.
- 表观遗传修饰 (DNA甲基化,基因质修饰,非编码RNA) 在瘤发病,进展和治疗耐药性方面至关重要.
- 像27-胆固醇这样的内源性化合物可以影响这些表观遗传变化.
研究的目的:
- 提供对乳腺癌表观遗传失调的全面概述.
- 突出表观遗传学对疾病进展,治疗耐药性和免疫逃避的影响.
- 确定理解表观遗传重编程的差距,并建议未来的研究方向.
主要方法:
- 关于乳腺癌表观遗传机制的文献综述.
- 分析表观遗传因素与瘤免疫微环境之间的相互作用.
- 检查当前的临床试验和治疗策略.
主要成果:
- 表观遗传变化有助于雌激素信号失调,内分泌疗法耐药性和代谢重新连接.
- 瘤免疫微环境在很大程度上是由表观遗传参与者塑造的.
- 已经证明,27-胆固醇会诱导ER阳性乳腺癌细胞的表观遗传变化.
结论:
- 表观遗传重编程是乳腺癌进化和治疗反应的核心.
- 向表观遗传途径为新型组合疗法提供了潜力.
- 需要进一步的研究,以充分阐明表观遗传机制,以改善临床管理和患者存活率.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K


